NATERA INC. COM

Public Equity (NASDAQ)PublicDiagnosticsBiotech

📍 Austin, TX, USA• Founded 2004• 1001-5000 employees

StreetZero Signal 60

Be the first to signal interest

About NATERA INC. COM

Natera, Inc. is a clinical laboratory company specializing in cell-free DNA testing for reproductive health, oncology, and organ transplantation. The company offers non-invasive prenatal testing (NIPT), hereditary cancer screening, and circulating tumor DNA assays. It operates as a public company listed on NASDAQ under the ticker NTRA.

LATEST FUNDINGRule 144

$484K

Announced 2026-10-28

🔒

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for NATERA INC. COM.

Create free account Sign in

Free plan includes 3 full deal profiles every month.

EMPLOYEES1001-5000

FOUNDED2004

HQAustin, TX, USA

Industry

Public Equity (NASDAQ)

Investors

Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.

Key highlights

Rule 144 placement of $483,945.96 completed
Company trades publicly on NASDAQ as NTRA
No investor details disclosed in filing

Ask StreetZero about NATERA INC. COM

Put our AI to work on this deal.

What is NATERA INC. COM's value proposition?Who are NATERA INC. COM's competitors?Why does this raise matter?Summarize NATERA INC. COM for an investor.

Similar companies

Other Public Equity (NASDAQ) deals, ranked by Signal.

Paylocity Holding Corporation

$66.0M

BENTLEY SYSTEMS INC

$67.5M

Crowdstrike Holdings, Inc.

$141.0M

Palo Alto Networks Inc

$201.4M

Source document & SEC filing

The source SEC filing and the cached document are available to members only. Sign in to view and download them.